# FDA recall D-183-2013

> **Hospira Inc.** · Class II · drug recall initiated 2013-01-08.

## Product

0.9% Sodium Chloride Injection USP, 100 mL   Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,

## Reason for recall

Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-183-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-01-08
- **Report date:** 2013-03-13
- **Termination date:** 2015-05-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-183-2013

## Citation

> AI Analytics. FDA recall D-183-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-183-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*